Pfizer vidste allerede 28. februar 2021,
at vi ville se et massivt antal bivirkninger og dødsfald,
helt specifikt 42.086 rapporter indeholdende
158.893 hændelser(herunder 1223 dødsfald).
FDA har frigivet den første omgang af dokumenter, som de har gennemgået, inden de licenserede Pfizers "vaccine". Efter at en gruppe på mere end 30 professorer og videnskabsmænd fra universiteter, herunder Yale, Harvard, UCLA og Brown, anlagde sag i septemberFDA har produceret de første 91+ sider med dokumenter fra Pfizers COVID-19-vaccinefil, og foreslår en gradvis udgivelse på 500 sider om måneden indtil færdiggørelsen af udgivelsen i år 2076.
Et af de fremlagte dokumenter er en kumulativ analyse af rapporter om uønskede hændelser efter autorisation modtaget til og med 28. februar 2021, to en halv måned efter, at vaccinen modtog nødgodkendelse. Dette dokument afspejler uønskede bivirkninger efter "vaccination", både i og uden for USA, frem til den 28. februar 2021.
Pfizer forklarer på side 6, at "På grund af det store antal spontane bivirkninger, der er modtaget for produktet, har Pfizer prioriteret behandlingen af alvorlige sager...", og at Pfizer "også har truffet flere handlinger for at hjælpe med at afhjælpe den store stigning i rapporter om uønskede bivirkninger", herunder "øgning af antallet af dataindtastning og sagsbehandlingskolleger" og "har indsat ca. [antal fjernet fra dokumenet] yderligere fuldtidsansatte."
Hvad angår mængden af indrapporterede bivirkningr, modtog Pfizer i de 2½ måned efter deres nødgodkendelse i alt 42.086 rapporter indeholdende 158.893 hændelser (herunder . De fleste af disse rapporter var fra USA og uforholdsmæssigt involverede kvinder (29.914 mod 9.182 leveret af mænd) og dem mellem 31 og 50 år (13.886 mod 21.325 for alle andre aldersgrupper tilsammen, med yderligere 6.876, hvis alder var ukendt). 25.957 af hændelserne blev klassificeret som "nervesystemlidelser"
Fuld download af dokumenterne
pd-production-111721
5.2-listing-of-clinical-sites-and-cvs-pages-1-41.pdf
5.2-tabular-listing.pdf
5.3.6-postmarketing-experience.pdf
BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txt
BATES-93_tv.xpt
pd-production-120121
Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf
Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf
pd-production-121321
BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt
BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt
BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt
BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt
BATES-FDA-CBER-2021-5683-0002376_relrec.xpt
BATES-FDA-CBER-2021-5683-0002377_supppr.xpt
BATES-FDA-CBER-2021-5683-0002378_ta.xpt
BATES-FDA-CBER-2021-5683-0002379_te.xpt
BATES-FDA-CBER-2021-5683-0002380_ti.xpt
CRFs-for-site-1055.pdf
signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf
STN-125742_0_0-Section-2.5-Clinical-Overview.pdf
STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf
STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf
pd-production-122221
Supplemental-Index-12-22-21.pdf
pd-production-123021
pd-production-123021/CRFs-for-site-1081.pdf
pd-production-011822
CRFs-for-site-1096.pdf
pd-production-013122
CRFs-for-site-1128.pdf
pd-production-030122
125742_S1_M1_356h.pdf
125742_S1_M1_3674.pdf
125742_S1_M1_cover.pdf
125742_S1_M1_debarment.pdf
125742_S1_M1_exclusivity-claim.pdf
125742_S1_M1_fast-track-designation.pdf
125742_S1_M1_financial-cert-3454.pdf
125742_S1_M1_financial-cert-bias.pdf
125742_S1_M1_ipsp-agreed-letter.pdf
125742_S1_M1_priority-review-request.pdf
125742_S1_M1_trans-of-oblig.pdf
125742_S1_M1_us-agent-authorization.pdf
125742_S1_M1_userfee.pdf
125742_S1_M1_waiver-req-designated-suffix.pdf
125742_S1_M2_22_introduction.pdf
125742_S1_M2_24_nonclinical-overview.pdf
125742_S1_M2_26_pharmkin-tabulated-summary.pdf
125742_S1_M2_26_pharmkin-written-summary.pdf
125742_S1_M2_27_literature-references.pdf
125742_S1_M2_27_synopses-indiv-studies.pdf
125742_S1_M4_4223_185350.pdf
125742_S1_M4_4223_R-20-0072.pdf
125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf
125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf
125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf
125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf
125742_S1_M5_5351_c4591001-fa-interim-errata.pdf
125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf
125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf
125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf
125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf
125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf
125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf
125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf
125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf
125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf
125742_S1_M5_c4591001-A-adrg.pdf
125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf
125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf
125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf
125742_S1_M5_c4591001-A-comorbidity-categories.pdf
125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf
125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf
125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf
125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf
125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf
125742_S1_M5_c4591001-A-report-cci-chf.pdf
125742_S1_M5_c4591001-A-report-cci-dementia.pdf
125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf
125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf
125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf
125742_S1_M5_c4591001-A-report-cci-leukemia.pdf
125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf
125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf
125742_S1_M5_c4591001-A-report-cci-mi.pdf
125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf
125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf
125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf
125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf
125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf
125742_S1_M5_c4591001-A-report-cci-renal.pdf
125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf
125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf
125742_S1_M5_c4591001-T-S-roadmap.pdf
125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf
125742_S1_M5_c4591001-T-S-suppl-arg.pdf
125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf
125742_S1_M5_CRF_c4591001-1085-10851018.pdf
125742_S1_M5_CRF_c4591001-1085-10851116.pdf
125742_S1_M5_CRF_c4591001-1085-10851129.pdf
125742_S1_M5_CRF_c4591001-1085-10851216.pdf
125742_S1_M5_CRF_c4591001-1085-10851246.pdf
FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt
/FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt
FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt
FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt
FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt
FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt
FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt
FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt
FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt
FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt
FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt
FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt
FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt
FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt
FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt
FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt
FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt
FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt
FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt
FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt
FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt
FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt
FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt
FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt
FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt
FDA-CBER-2021-5683-0023150 to -0023454_125742_S1_M5_c4591001-A-define.xml
FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl
FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx
FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx
FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx
FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx
FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx
FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx
FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx
FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx
FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx
FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx
FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx
FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx
FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx
FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx
FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx
FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx
FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx
FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx
FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx
FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx
FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx
FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx
FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx
FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx
FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx
FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx
pd-production-032422
125742_S1_M1_priority-review-request.pdf
pd-production-040122
125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdf
125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf
125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdf
125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdf
125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdf
125742_S1_M5_5351_c4591001-fa-interim-publications.pdf
125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdf
125742_S1_M5_5351_c4591001-fa-interim-randomization.pdf
125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdf
125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdf
125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdf
125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf
125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdf
reissue_5.3.6 postmarketing experience.pdf
pd-production-050222
125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf
125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf
125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf
125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf
125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf
125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf
125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf
125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf
125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf
125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf
125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf
125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf
125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf
125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf
125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf
125742_S1_M5_5351_bnt162-01-interim3-sap.pdf
125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf
125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf
125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf
125742_S1_M5_5351_bnt162-01_10010.pdf
125742_S1_M5_5351_bnt162-01_10075.pdf
125742_S1_M5_5351_bnt162-01_20116.pdf
125742_S1_M5_5351_bnt162-01_20215.pdf
125742_S1_M5_5351_bnt162-01_20242.pdf
125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf
125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf
125742_S1_M5_bnt162-01-A-adrg.pdf
125742_S1_M5_bnt162-01-S-acrf.pdf
125742_S1_M5_bnt162-01-S-csdrg.pdf
125742_S1_M5_c4591001-S-acrf.pdf
125742_S1_M5_c4591001-S-csdrg.pdf
125742_S1_M5_c4591001-S-Supp-acrf.pdf
125742_S1_M5_CRF_c4591001-1001-10011093.pdf
125742_S1_M5_CRF_c4591001-1001-10011100.pdf
125742_S1_M5_CRF_c4591001-1001-10011135.pdf
125742_S1_M5_CRF_c4591001-1003-10031038.pdf
125742_S1_M5_CRF_c4591001-1003-10031065.pdf
125742_S1_M5_CRF_c4591001-1003-10031111.pdf
125742_S1_M5_CRF_c4591001-1003-10031113.pdf
125742_S1_M5_CRF_c4591001-1003-10031149.pdf
125742_S1_M5_CRF_c4591001-1003-10031186.pdf
125742_S1_M5_CRF_c4591001-1003-10031197.pdf
125742_S1_M5_CRF_c4591001-1003-10031207.pdf
125742_S1_M5_CRF_c4591001-1005-10051047.pdf
125742_S1_M5_CRF_c4591001-1005-10051054.pdf
125742_S1_M5_CRF_c4591001-1005-10051069.pdf
125742_S1_M5_CRF_c4591001-1005-10051214.pdf
125742_S1_M5_CRF_c4591001-1005-10051293.pdf
125742_S1_M5_CRF_c4591001-1005-10051347.pdf
125742_S1_M5_CRF_c4591001-1005-10051387.pdf
125742_S1_M5_CRF_c4591001-1005-10051411.pdf
125742_S1_M5_CRF_c4591001-1006-10061020.pdf
125742_S1_M5_CRF_c4591001-1006-10061040.pdf
125742_S1_M5_CRF_c4591001-1006-10061052.pdf
125742_S1_M5_CRF_c4591001-1006-10061094.pdf
125742_S1_M5_CRF_c4591001-1006-10061098.pdf
125742_S1_M5_CRF_c4591001-1006-10061176.pdf
FDA-CBER-2021-5683-0058316 to -0058458_125742_S1_M5_c4591001-A-Supp-define.xml
FDA-CBER-2021-5683-0058459 to -0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl
FDA-CBER-2021-5683-0058479 to -0058594_125742_S1_M5_c4591001-S-define.xml
FDA-CBER-2021-5683-0058595 to -0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl
FDA-CBER-2021-5683-0058615 to -0058652_125742_S1_M5_c4591001-S-Supp-define.xml
FDA-CBER-2021-5683-0058653 to -0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl
FDA-CBER-2021-5683-0058676 to -0058794_125742_S1_M5_bnt162-01-A-define.xml
FDA-CBER-2021-5683-0058795 to -0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl
FDA-CBER-2021-5683-0058829 to -0058954_125742_S1_M5_bnt162-01-S-define.xml
FDA-CBER-2021-5683-0058955 to -0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl
FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt
FDA-CBER-2021-5683-0065774 to -0066700_125742_S1_M5_c4591001-A-D-addv.xpt
FDA-CBER-2021-5683-0066701 to -0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt
FDA-CBER-2021-5683-0123168 to -0126026_125742_S1_M5_c4591001-A-D-adva.xpt
pd-production-060122
125742_S1_M2_summary-biopharm.pdf
125742_S1_M5_5314_shi-sop-10011.pdf
125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf
125742_S1_M5_5351_c4591001-fa-interim-discontinued-patients.pdf
125742_S1_M5_5351_c4591001-fa-interim-patient-batches.pdf
125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-patient-batches.pdf
125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf
125742_S1_M5_5351_c4591001-interim-mth6-randomization.pdf
125742_S1_M5_CRF_c4591001-1007-10071050.pdf
125742_S1_M5_CRF_c4591001-1007-10071097.pdf
125742_S1_M5_CRF_c4591001-1007-10071101.pdf
125742_S1_M5_CRF_c4591001-1007-10071117.pdf
125742_S1_M5_CRF_c4591001-1007-10071124.pdf
125742_S1_M5_CRF_c4591001-1007-10071159.pdf
125742_S1_M5_CRF_c4591001-1007-10071192.pdf
125742_S1_M5_CRF_c4591001-1007-10071276.pdf
125742_S1_M5_CRF_c4591001-1007-10071280.pdf
125742_S1_M5_CRF_c4591001-1007-10071306.pdf
125742_S1_M5_CRF_c4591001-1007-10071315.pdf
125742_S1_M5_CRF_c4591001-1007-10071347.pdf
125742_S1_M5_CRF_c4591001-1007-10071441.pdf
125742_S1_M5_CRF_c4591001-1007-10071443.pdf
125742_S1_M5_CRF_c4591001-1008-10081056.pdf
125742_S1_M5_CRF_c4591001-1008-10081152.pdf
125742_S1_M5_CRF_c4591001-1008-10081184.pdf
125742_S1_M5_CRF_c4591001-1008-10081337.pdf
125742_S1_M5_CRF_c4591001-1008-10081603.pdf
125742_S1_M5_CRF_c4591001-1008-10081628.pdf
125742_S1_M5_CRF_c4591001-1008-10081667.pdf
125742_S1_M5_CRF_c4591001-1009-10091123.pdf
125742_S1_M5_CRF_c4591001-1009-10091128.pdf
125742_S1_M5_CRF_c4591001-1009-10091135.pdf
125742_S1_M5_CRF_c4591001-1009-10091149.pdf
125742_S1_M5_CRF_c4591001-1011-10111029.pdf
125742_S1_M5_CRF_c4591001-1011-10111181.pdf
125742_S1_M5_CRF_c4591001-1012-10121097.pdf
125742_S1_M5_CRF_c4591001-1012-10121112.pdf
125742_S1_M5_CRF_c4591001-1012-10121163.pdf
125742_S1_M5_CRF_c4591001-1013-10131084.pdf
125742_S1_M5_CRF_c4591001-1013-10131089.pdf
125742_S1_M5_CRF_c4591001-1013-10131165.pdf
125742_S1_M5_CRF_c4591001-1013-10131176.pdf
125742_S1_M5_CRF_c4591001-1013-10131190.pdf
125742_S1_M5_CRF_c4591001-1013-10131229.pdf
125742_S1_M5_CRF_c4591001-1013-10131255.pdf
125742_S1_M5_CRF_c4591001-1013-10131386.pdf
125742_S1_M5_CRF_c4591001-1013-10131517.pdf
125742_S1_M5_CRF_c4591001-1013-10131554.pdf
125742_S1_M5_CRF_c4591001-1013-10131653.pdf
125742_S1_M5_CRF_c4591001-1013-10131656.pdf
125742_S1_M5_CRF_c4591001-1013-10131658.pdf
125742_S1_M5_CRF_c4591001-1013-10131699.pdf
125742_S1_M5_CRF_c4591001-1013-10131718.pdf
125742_S1_M5_CRF_c4591001-1013-10131786.pdf
125742_S1_M5_CRF_c4591001-1015-10151011.pdf
125742_S1_M5_CRF_c4591001-1015-10151035.pdf
125742_S1_M5_CRF_c4591001-1015-10151047.pdf
125742_S1_M5_CRF_c4591001-1015-10151071.pdf
125742_S1_M5_CRF_c4591001-1015-10151089.pdf
125742_S1_M5_CRF_c4591001-1015-10151101.pdf
125742_S1_M5_CRF_c4591001-1015-10151134.pdf
125742_S1_M5_CRF_c4591001-1015-10151225.pdf
125742_S1_M5_CRF_c4591001-1015-10151238.pdf
125742_S1_M5_CRF_c4591001-1081-10811194 reissue.pdf
125742_S1_M5_CRF_c4591001-1128-11281009 reissue.pdf
FDA-CBER-2021-5683-0142307 to -0149081_125742_S1_M5_c4591001-A-Supp-D-adcevd.xpt
FDA-CBER-2021-5683-0149082 to -0158559_125742_S1_M5_c4591001-S-D-ce.xpt
FDA-CBER-2021-5683-0158560 to -0159486_125742_S1_M5_c4591001-S-D-dv.xpt
FDA-CBER-2021-5683-0159487 to -0162689_125742_S1_M5_c4591001-S-D-ec.xpt
FDA-CBER-2021-5683-0162690 to -0165892_125742_S1_M5_c4591001-S-D-ex.xpt
FDA-CBER-2021-5683-0168683 to -0169081_125742_S1_M5_c4591001-S-D-suppcm.xpt
FDA-CBER-2021-5683-0169082 to -0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt
FDA-CBER-2021-5683-0171524 to -0174606_125742_S1_M5_c4591001-S-D-suppds.xpt
FDA-CBER-2021-5683-0174607 to -0178318_125742_S1_M5_c4591001-S-D-suppdv.xpt
FDA-CBER-2021-5683-0178319 to -0180190_125742_S1_M5_c4591001-S-D-suppho.xpt
FDA-CBER-2021-5683-0180191 to -0182980_125742_S1_M5_c4591001-S-D-suppis.xpt
FDA-CBER-2021-5683-0182981 to -0187905_125742_S1_M5_c4591001-S-D-suppmh.xpt
FDA-CBER-2021-5683-0187906 to -0196048_125742_S1_M5_c4591001-S-D-suppvs.xpt
FDA-CBER-2021-5683-0196049 to -0205317_125742_S1_M5_c4591001-S-Supp-D-ce.xpt
FDA-CBER-2021-5683-0205318 to -0208520_125742_S1_M5_c4591001-S-Supp-D-ex.xpt
FDA-CBER-2021-5683-0208521 to -0216666_125742_S1_M5_c4591001-S-Supp-D-suppvs.xpt
pd-production-070122
125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf
125742_S1_M5_5351_c4591001-fa-interim-sap.pdf
125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.pdf
125742_S1_M5_5351_c4591001-interim-mth6-compliance-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf
125742_S1_M5_5351_c4591001-interim-mth6-efficacy-response.pdf
125742_S1_M5_5351_c4591001-interim-mth6-errata.pdf
125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients.pdf
125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf
125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf
125742_S1_M5_5351_c4591001-interim-mth6-protocol-deviations.pdf
125742_S1_M5_5351_c4591001-interim-mth6-sap.pdf
125742_S2_M1_com195lkz-carton-kzoo.pdf
125742_S2_M1_com195lpus-carton-puurs.pdf
125742_S2_M1_com25ctkz-carton-kzoo.pdf
125742_S2_M1_com25ctpus-carton-puurs.pdf
125742_S2_M1_comvlabkz-vial-kzoo.pdf
125742_S2_M1_comvlabp-vial-puurs.pdf
125742_S2_M1_fk-diluent-carton.pdf
125742_S2_M1_fk-diluent-stamp.pdf
125742_S2_M1_hospira-diluent-carton.pdf
125742_S2_M1_hospira-diluent-label.pdf
125742_S2_M1_loa-dmf-011321-vials.pdf
125742_S2_M1_loa-dmf-011793-vials.pdf
125742_S2_M1_loa-dmf-011820-vials.pdf
125742_S2_M1_loa-dmf-012683-vials.pdf
125742_S2_M1_loa-dmf-031786-vials.pdf
125742_S2_M1_loa-dmf-10953-stopper.pdf
125742_S2_M1_right-of-reference.pdf
125742_S2_M5_5354_wi235284-protocol.pdf
FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.xpt
FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.xpt
FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.xpt
FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.xpt
FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.xpt
FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.xpt
FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.xpt
FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.xpt
FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.xpt
FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.xpt
pd-production-080122
125742_S2_M5_54_ezeanolue-e-2019.pdf
125742_S2_3.PSUR-1.pdf
125742_S2_3_pfizer-report
FDA-CBER-2021-5683-0396187_125742_S1_M5_c4591001-S-D-pr.xpt
FDA-CBER-2021-5683-0396188 to -0396192_125742_S1_M5_c4591001-S-D-suppmo.xpt
FDA-CBER-2021-5683-0396193 to -0396194_125742_S1_M5_c4591001-S-D-supppe.xpt
FDA-CBER-2021-5683-0396195_125742_S1_M5_bnt162-01-S-D-relrec.xpt
FDA-CBER-2021-5683-0396196_125742_S1_M5_bnt162-01-S-D-supppe.xpt
FDA-CBER-2021-5683-0396197_125742_S1_M5_bnt162-01-S-D-supprp.xpt
FDA-CBER-2021-5683-0396198_125742_S1_M5_bnt162-01-S-D-te.xpt
FDA-CBER-2021-5683-0396199_125742_S1_M5_bnt162-01-S-D-tv.xpt
pd-production-010323
106A_2_BLA_125742-0_08-20-2021_Telecon_Labeling via FAX_e.pdf
10_BLA_125742-0_06-29-2021_Filing_Meeting_Summary.pdf
114A_2_BLA_125742-0_08-21-2021_Telecon_Labeling via FAX_e.pdf
125742_S12_M1_13jul2021-response.pdf
125742_S12_M1_waiver-req-preservative.pdf
125742_S13_M5_5351_c4591001-adae-hiv-listing.pdf
125742_S13_M5_5351_c4591001-narrative-1226-12262255.pdf
125742_S16_M1_ped-studies-deferral-track-change.pdf
125742_S16_M1_psp-track.pdf
125742_S1_M5_5351_c4591001-interim-mth6-iec-irb-consent-form.pdf
125742_S21_M1_pharmacovigilance-plan.pdf
125742_S21_M1_pvp-track.pdf
125742_S27_M1_response-29jul2021.pdf
125742_S28_M1_response-22jul2021-followup.pdf
125742_S29_M1_lab-1448-0-2-annotated.pdf
125742_S29_M1_lab-1448-0-2-pkg-insert-clean.pdf
125742_S29_M1_lab-1448-0-2-pkg-insert-track.pdf
125742_S33_M5_5351_c4591001-508-efficacy-tables.pdf
125742_S38_M5_c4591001-508-safety-tables.pdf
125742_S39_M1_5351_c4591001-ve-tables.pdf
125742_S39_M1_lab-1448-0-3-annotated.pdf
125742_S39_M1_lab-1448-0-3-pkg-insert-clean.pdf
125742_S39_M1_lab-1448-0-3-pkg-insert-track.pdf
125742_S41_M1_c4591001-ve-tables.pdf
125742_S46_M1_carton-com195lkz-kzoo.pdf
125742_S46_M1_carton-com195lpus-puurs.pdf
125742_S46_M1_carton-com25ctkz-kzoo.pdf
125742_S46_M1_carton-com25ctpus-puurs.pdf
125742_S46_M1_label-comvlabkz-kzoo.pdf
125742_S46_M1_label-comvlabp-puurs.pdf
125742_S46_M1_sticker-comdilrm.pdf
125742_S51_M1_lab-1448-0-4-annotated.pdf
125742_S51_M1_lab-1448-0-4-pkg-insert-clean.pdf
125742_S51_M1_lab-1448-0-4-pkg-insert-track.pdf
125742_S51_M5_5351_c4591001-followup-table.pdf
125742_S54_M1_carton-com195lkz-kzoo.pdf
125742_S54_M1_carton-com195lpus-puurs.pdf
125742_S54_M1_carton-com25ctkz-kzoo.pdf
125742_S54_M1_carton-com25ctpus-puurs.pdf
125742_S58_M1_lab-1448-0-5-annotated.pdf
125742_S58_M1_lab-1448-0-5-pkg-insert-clean.pdf
125742_S58_M1_lab-1448-0-5-pkg-insert-track.pdf
125742_S64_M1_carton-com195lkz-kzoo.pdf
125742_S64_M1_carton-com195lpus-puurs.pdf
125742_S64_M1_carton-com25ctkz-kzoo.pdf
125742_S64_M1_carton-com25ctpus-puurs.pdf
125742_S64_M1_label-comvlabkz-kzoo.pdf
125742_S64_M1_label-comvlabp-puurs.pdf
125742_S64_M1_sticker-comdilrm.pdf
125742_S68_M1_lab-1448-0-6-annotated.pdf
125742_S68_M1_lab-1448-0-6-pkg-insert-clean.pdf
125742_S68_M1_lab-1448-0-6-pkg-insert-track.pdf
125742_S6_M5_5351_c4591001-sequencing-listings.pdf
125742_S70_M1_lab-1448-0-7-annotated.pdf
125742_S70_M1_lab-1448-0-7-pkg-insert-clean.pdf
125742_S70_M1_lab-1448-0-7-pkg-insert-track.pdf
125742_S73_M1_lab-1448-0-8-annotated.pdf
125742_S73_M1_lab-1448-0-8-pkg-insert-clean.pdf
125742_S73_M1_lab-1448-0-8-pkg-insert-track.pdf
125742_S76_M1_lab-1448-0-9-annotated.pdf
125742_S76_M1_lab-1448-0-9-pkg-insert-clean.pdf
125742_S76_M1_lab-1448-0-9-pkg-insert-track.pdf
125742_S79_M1_lab-1448-1-0-pkg-insert-clean.pdf
125742_S7_M1_response-08jun2021.pdf
125742_S80_M1_lab-1448-1-0-pkg-insert-clean.pdf
126_BLA 125742-0_08-23-2021_Memo_Other.pdf
130_BLA _125742-0_09-01-2021_Committee Memo_Labeling.pdf
13_BLA_125742-0_07-02-2021_Committee Memo_APLB.pdf
36A_BLA_125742-0_07-28-2021_Telecon_Labeling Target Cl.pdf
4_BLA_125742-0_06-03-2021_First_Committee_Meeting_Summary.pdf
72A_BLA_125742-0_08-13-2021_Telecon_Labeling via FAX_e.pdf
77_BLA_125742-0_08-17-2021_Memo_Lot Release Clearance.pdf
78_BLA_125742-0_08-17-2021_Memo_Other.pdf
7_BLA_125742-0_06-17-2021_Memo_Other.pdf
82A_BLA_125742-0_08-17-2021_Telecon_Labeling via FAX_e.pdf
91A_2_BLA_125742-0_08-18-2021_Telecon_Labeling via FAX_e.pdf
98A_BLA_125742-0_08-19-2021_Telecon_Labeling via FAX_e.pdf
FDA-CBER-2021-5683-0652385-0652413-125742_S29_M1_lab-1448-0-2-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652414-0652442-125742_S29_M1_lab-1448-0-2-pkg-insert-track.doc
FDA-CBER-2021-5683-0652443-0652471-125742_S33_M5_5351_c4591001-508-efficacy-tables.doc
FDA-CBER-2021-5683-0652472-0652503-125742_S38_M5_c4591001-508-safety-tables.doc.docx
FDA-CBER-2021-5683-0652504-0652525-125742_S39_M1_lab-1448-0-3-pkg-insert-track.doc
FDA-CBER-2021-5683-0652526-0652547-125742_S39_M1_lab-1448-0-3-annotated.doc
FDA-CBER-2021-5683-0652548-0652569-125742_S39_M1_lab-1448-0-3-pkg-insert-clean.doc
FDA-CBER-2021-5683-0652570-0652590-125742_S51_M1_lab-1448-0-4-pkg-insert-track.docx
FDA-CBER-2021-5683-0652591-0652611-125742_S51_M1_lab-1448-0-4-annotated.docx
FDA-CBER-2021-5683-0652612-0652632-125742_S51_M1_lab-1448-0-4-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652633-0652652-125742_S58_M1_lab-1448-0-5-annotated.docx
FDA-CBER-2021-5683-0652653-0652672-125742_S58_M1_lab-1448-0-5-pkg-insert-track.docx
FDA-CBER-2021-5683-0652673-0652692-125742_S58_M1_lab-1448-0-5-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652693-0652713-125742_S68_M1_lab-1448-0-6-annotated.docx
FDA-CBER-2021-5683-0652714-0652734-125742_S68_M1_lab-1448-0-6-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652735-0652755-125742_S68_M1_lab-1448-0-6-pkg-insert-track.docx
FDA-CBER-2021-5683-0652756-0652776-125742_S70_M1_lab-1448-0-7-annotated.docx
FDA-CBER-2021-5683-0652777-0652797-125742_S70_M1_lab-1448-0-7-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652798-0652818-125742_S70_M1_lab-1448-0-7-pkg-insert-track.docx
FDA-CBER-2021-5683-0652819-0652838-125742_S73_M1_lab-1448-0-8-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652839-0652858-125742_S73_M1_lab-1448-0-8-annotated.docx
FDA-CBER-2021-5683-0652859-0652878-125742_S73_M1_lab-1448-0-8-pkg-insert-track.docx
FDA-CBER-2021-5683-0652879-0652898-125742_S76_M1_lab-1448-0-9-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652899-0652919-125742_S76_M1_lab-1448-0-9-pkg-insert-track.docx
FDA-CBER-2021-5683-0652920-0652940-125742_S76_M1_lab-1448-0-9-annotated.docx
FDA-CBER-2021-5683-0652941-0652960-125742_S79_M1_lab-1448-1-0-pkg-insert-clean.docx
FDA-CBER-2021-5683-0652961-0652980-125742_S80_M1_lab-1448-1-0-pkg-insert-clean.docx
pd-production-020123
125742_S1_M2_2.6.1 introduction.pdf125742_S1_M2_2.6.2 pharmacol-written-summary.pdf
125742_S1_M2_2.6.3.1 pharmacol-tabulated-summary.pdf
125742_S1_M2_2.6.6 toxicology-written-summary.pdf
125742_S1_M2_2.6.7.1toxicology-tabulated-summary.pdf
125742_S1_M4_4.2.1 r-20-0085.pdf
125742_S1_M4_4.2.1 r-20-0112.pdf
125742_S1_M4_4.2.1 r-20-0211.pdf
125742_S1_M4_4.2.1 vr-vtr-10741.pdf
125742_S1_M4_4.2.2 072424.pdf
125742_S1_M4_4.2.2.1 vr-vtr-10671.pdf
125742_S1_M4_4.2.2.4 01049-20008.pdf
125742_S1_M4_4.2.2.4 01049-20009.pdf
125742_S1_M4_4.2.2.4 01049-20010.pdf
125742_S1_M4_4.2.2.4 01049-20020.pdf
125742_S1_M4_4.2.2.4 01049-20021.pdf
125742_S1_M4_4.2.2.4 01049-20022.pdf
125742_S1_M4_4.2.2.4 043725.pdf
125742_S1_M4_4.2.3.2 20gr142.pdf
125742_S1_M4_4.3 munster-jv-2020.pdf
pd-production-030123
125742_S1_M4_20gr142_nsdrg.pdf125742_S1_M4_38166_nsdrg.pdf
125742_S1_M4_4.2.3.2 38166.pdf
FDA-CBER-2021-5683-0767981-0768062_125742_S1_M4_20gr142_define.xml
FDA-CBER-2021-5683-0768063-0768092_125742_S1_M4_20gr142_define2-0-0.xsl
FDA-CBER-2021-5683-0768093-0768158_125742_S1_M4_38166_define.xml
FDA-CBER-2021-5683-0768159-0768188_125742_S1_M4_38166_define2-0-0.xsl
pd-production-040323
125742_S14_M1_cover.pdf125742_S1_M5_5314_vr-mqr-10211-att-01.pdf
125742_S1_M5_5314_vr-mqr-10211.pdf
125742_S1_M5_5314_vr-mqr-10212-att-01.pdf
125742_S1_M5_5314_vr-mqr-10212.pdf
125742_S1_M5_5314_vr-mqr-10214-att-01.pdf
125742_S1_M5_5314_vr-mqr-10214-att-02.pdf
125742_S1_M5_5314_vr-mqr-10214-att-03.pdf
125742_S1_M5_5314_vr-mqr-10214.pdf
125742_S1_M5_5314_vr-mvr-10080-att-01.pdf
125742_S1_M5_5314_vr-mvr-10080-att-02.pdf
125742_S1_M5_5314_vr-mvr-10080.pdf
125742_S1_M5_5314_vr-mvr-10081-att-01.pdf
125742_S1_M5_5314_vr-mvr-10081.pdf
125742_S1_M5_5314_vr-mvr-10083-att01.pdf
125742_S1_M5_5314_vr-mvr-10083-att02.pdf
125742_S1_M5_5314_vr-mvr-10083-att03.pdf
125742_S1_M5_5314_vr-mvr-10083-att04.pdf
125742_S1_M5_5314_vr-mvr-10083.pdf
125742_S1_M5_5314_vr-sop-lc-11120.pdf
125742_S1_M5_5314_vr-tm-10293.pdf
125742_S1_M5_5314_vr-tm-10294.pdf
125742_S1_M5_5314_vr-tm-10298.pdf
125742_S1_M5_5314_vr-tm-10304.pdf
125742_S1_M5_5351_c4591001-fa-interim-report-body.pdf
125742_S1_M5_5351_c4591001-fa-interim-synopsis.pdf
125742_S1_M5_5351_c4591001-interim-mth6-report-body.pdf
125742_S1_M5_5351_c4591001-interim-mth6-synopsis.pdf
125742_S2_M1_cover.pdf
125742_S2_M1_dca-anaphylactic-reaction.pdf
125742_S2_M1_dca-vaed.pdf
125742_S2_M1_diluent-labeling-proposal.pdf
125742_S2_M1_loa-dmf-9543-vials.pdf
125742_S2_M1_pllr-cumulative-review.pdf
125742_S2_M1_pllr-lit-search-summary.pdf
125742_S2_M1_pllr-waiver-request-drug-utilization.pdf
125742_S2_M1_pllr-waiver-request-pregnancy-registry.pdf
125742_S2_M5_5351_c4591007-protocol-amend1.pdf
125742_S2_M5_5351_c4591015-protocol-amend2.pdf
125742_S2_M5_5354_c4591008-protocol.pdf
125742_S2_M5_5354_c4591009-protocol-synopsis.pdf
125742_S2_M5_5354_c4591011-protocol.pdf
125742_S2_M5_5354_c4591012-protocol.pdf
125742_S2_M5_5354_c4591014-protocol.pdf
125742_S2_M5_5354_c4591022-protocol.pdf
125742_S2_M5_5354_wi255886-protocol.pdf
125742_S3_M1_cover.pdf
125742_S3_M1_proprietary-name.pdf
125742_S4_M1_cover.pdf
125742_S4_M1_response-18-may-2021-datasets.pdf
125742_S7_M5_5351_bnt162-01-interim3-reports.pdf
pd-production-050123
125742_S1_M5_CRF_c4591001-1016-10161042.pdf125742_S1_M5_CRF_c4591001-1016-10161087.pdf
125742_S1_M5_CRF_c4591001-1016-10161103.pdf
125742_S1_M5_CRF_c4591001-1016-10161120.pdf
125742_S1_M5_CRF_c4591001-1016-10161128.pdf
125742_S1_M5_CRF_c4591001-1016-10161199.pdf
125742_S1_M5_CRF_c4591001-1016-10161265.pdf
125742_S1_M5_CRF_c4591001-1016-10161277.pdf
125742_S1_M5_CRF_c4591001-1016-10161289.pdf
125742_S1_M5_CRF_c4591001-1018-10181031.pdf
125742_S1_M5_CRF_c4591001-1018-10181090.pdf
125742_S1_M5_CRF_c4591001-1018-10181111.pdf
125742_S1_M5_CRF_c4591001-1018-10181132.pdf
125742_S1_M5_CRF_c4591001-1018-10181159.pdf
125742_S1_M5_CRF_c4591001-1036-10361140.pdf
125742_S1_M5_CRF_c4591001-1066-10661202.pdf
125742_S1_M5_CRF_c4591001-1066-10661242.pdf
125742_S1_M5_CRF_c4591001-1066-10661350.pdf
125742_S1_M5_CRF_c4591001-1091-10911002.pdf
125742_S1_M5_CRF_c4591001-1091-10911170.pdf
125742_S1_M5_CRF_c4591001-1091-10911197.pdf
125742_S1_M5_CRF_c4591001-1091-10911213.pdf
125742_S1_M5_CRF_c4591001-1091-10911247.pdf
125742_S1_M5_CRF_c4591001-1091-10911274.pdf
125742_S1_M5_CRF_c4591001-1091-10911297.pdf
125742_S1_M5_CRF_c4591001-1091-10911299.pdf
125742_S1_M5_CRF_c4591001-1091-10911300.pdf
125742_S1_M5_CRF_c4591001-1112-11121118.pdf
125742_S1_M5_CRF_c4591001-1112-11121122.pdf
125742_S1_M5_CRF_c4591001-1112-11121193.pdf
125742_S1_M5_CRF_c4591001-1112-11121255.pdf
125742_S1_M5_CRF_c4591001-1112-11121301.pdf
125742_S1_M5_CRF_c4591001-1112-11121337.pdf
125742_S1_M5_CRF_c4591001-1114-11141006.pdf
125742_S1_M5_CRF_c4591001-1114-11141050.pdf
125742_S1_M5_CRF_c4591001-1114-11141075.pdf
125742_S1_M5_CRF_c4591001-1114-11141080.pdf
125742_S1_M5_CRF_c4591001-1117-11171036.pdf
125742_S1_M5_CRF_c4591001-1117-11171058.pdf
125742_S1_M5_CRF_c4591001-1117-11171079.pdf
125742_S1_M5_CRF_c4591001-1117-11171086.pdf
125742_S1_M5_CRF_c4591001-1117-11171088.pdf
125742_S1_M5_CRF_c4591001-1117-11171121.pdf
125742_S1_M5_CRF_c4591001-1117-11171141.pdf
125742_S1_M5_CRF_c4591001-1117-11171146.pdf
125742_S1_M5_CRF_c4591001-1117-11171167.pdf
125742_S1_M5_CRF_c4591001-1117-11171186.pdf
125742_S1_M5_CRF_c4591001-1118-11181013.pdf
125742_S1_M5_CRF_c4591001-1118-11181031.pdf
125742_S1_M5_CRF_c4591001-1118-11181044.pdf
125742_S1_M5_CRF_c4591001-1118-11181057.pdf
125742_S1_M5_CRF_c4591001-1118-11181074.pdf
125742_S1_M5_CRF_c4591001-1118-11181123.pdf
125742_S1_M5_CRF_c4591001-1120-11201002.pdf
125742_S1_M5_CRF_c4591001-1120-11201050.pdf
125742_S1_M5_CRF_c4591001-1120-11201059.pdf
125742_S1_M5_CRF_c4591001-1120-11201127.pdf
125742_S1_M5_CRF_c4591001-1120-11201266.pdf
125742_S1_M5_CRF_c4591001-1120-11201350.pdf
125742_S1_M5_CRF_c4591001-1120-11201432.pdf
125742_S1_M5_CRF_c4591001-1121-11211112.pdf
125742_S1_M5_CRF_c4591001-1129-11291005.pdf
125742_S1_M5_CRF_c4591001-1129-11291032.pdf
125742_S1_M5_CRF_c4591001-1129-11291037.pdf
125742_S1_M5_CRF_c4591001-1129-11291045.pdf
125742_S1_M5_CRF_c4591001-1129-11291046.pdf
125742_S1_M5_CRF_c4591001-1129-11291059.pdf
125742_S1_M5_CRF_c4591001-1129-11291074.pdf
125742_S1_M5_CRF_c4591001-1129-11291095.pdf
125742_S1_M5_CRF_c4591001-1129-11291127.pdf
125742_S1_M5_CRF_c4591001-1129-11291138.pdf
125742_S1_M5_CRF_c4591001-1129-11291161.pdf
125742_S1_M5_CRF_c4591001-1129-11291166.pdf
125742_S1_M5_CRF_c4591001-1129-11291183.pdf
125742_S1_M5_CRF_c4591001-1129-11291260.pdf
125742_S1_M5_CRF_c4591001-1133-11331006.pdf
125742_S1_M5_CRF_c4591001-1133-11331147.pdf
125742_S1_M5_CRF_c4591001-1133-11331207.pdf
125742_S1_M5_CRF_c4591001-1133-11331317.pdf
125742_S1_M5_CRF_c4591001-1133-11331537.pdf
125742_S1_M5_CRF_c4591001-1133-11331640.pdf
125742_S1_M5_CRF_c4591001-1134-11341019.pdf
125742_S1_M5_CRF_c4591001-1134-11341058.pdf
125742_S1_M5_CRF_c4591001-1134-11341085.pdf
125742_S1_M5_CRF_c4591001-1134-11341153.pdf
125742_S1_M5_CRF_c4591001-1134-11341174.pdf
125742_S1_M5_CRF_c4591001-1134-11341250.pdf
125742_S1_M5_CRF_c4591001-1134-11341327.pdf
125742_S1_M5_CRF_c4591001-1134-11341378.pdf
125742_S1_M5_CRF_c4591001-1134-11341432.pdf
125742_S1_M5_CRF_c4591001-1145-11451042.pdf
125742_S1_M5_CRF_c4591001-1145-11451055.pdf
125742_S1_M5_CRF_c4591001-1145-11451056.pdf
125742_S1_M5_CRF_c4591001-1145-11451059.pdf
125742_S1_M5_CRF_c4591001-1145-11451063.pdf
125742_S1_M5_CRF_c4591001-1145-11451076.pdf
125742_S1_M5_CRF_c4591001-1146-11461015.pdf
125742_S1_M5_CRF_c4591001-1146-11461109.pdf
125742_S1_M5_CRF_c4591001-1146-11461133.pdf
125742_S1_M5_CRF_c4591001-1146-11461152.pdf
125742_S1_M5_CRF_c4591001-1146-11461161.pdf
125742_S1_M5_CRF_c4591001-1146-11461181.pdf
125742_S1_M5_CRF_c4591001-1146-11461191.pdf
125742_S1_M5_CRF_c4591001-1146-11461200.pdf
125742_S1_M5_CRF_c4591001-1146-11461235.pdf
125742_S1_M5_CRF_c4591001-1146-11461264.pdf
125742_S1_M5_CRF_c4591001-1146-11461302.pdf
125742_S1_M5_CRF_c4591001-1147-11471007.pdf
125742_S1_M5_CRF_c4591001-1147-11471230.pdf
125742_S1_M5_CRF_c4591001-1147-11471239.pdf
125742_S1_M5_CRF_c4591001-1149-11491239.pdf
125742_S1_M5_CRF_c4591001-1149-11491313.pdf
125742_S1_M5_CRF_c4591001-1150-11501001.pdf
125742_S1_M5_CRF_c4591001-1150-11501022.pdf
125742_S1_M5_CRF_c4591001-1150-11501037.pdf
125742_S1_M5_CRF_c4591001-1150-11501069.pdf
125742_S1_M5_CRF_c4591001-1150-11501084.pdf
125742_S1_M5_CRF_c4591001-1150-11501093.pdf
125742_S1_M5_CRF_c4591001-1150-11501153.pdf
125742_S1_M5_CRF_c4591001-1167-11671009.pdf
125742_S1_M5_CRF_c4591001-1167-11671069.pdf
125742_S1_M5_CRF_c4591001-1167-11671077.pdf
125742_S1_M5_CRF_c4591001-1167-11671085.pdf
125742_S1_M5_CRF_c4591001-1167-11671175.pdf
125742_S1_M5_CRF_c4591001-1168-11681083.pdf
125742_S1_M5_CRF_c4591001-1168-11681225.pdf
125742_S1_M5_CRF_c4591001-1169-11691010.pdf
125742_S1_M5_CRF_c4591001-1169-11691055.pdf
125742_S1_M5_CRF_c4591001-1169-11691056.pdf
125742_S1_M5_CRF_c4591001-1174-11741042.pdf
125742_S1_M5_CRF_c4591001-1178-11781012.pdf
125742_S1_M5_CRF_c4591001-1178-11781015.pdf
125742_S1_M5_CRF_c4591001-1178-11781025.pdf
125742_S1_M5_CRF_c4591001-1178-11781048.pdf
125742_S1_M5_CRF_c4591001-1178-11781061.pdf
125742_S1_M5_CRF_c4591001-1178-11781073.pdf
125742_S1_M5_CRF_c4591001-1178-11781107.pdf
125742_S1_M5_CRF_c4591001-1178-11781122.pdf
125742_S1_M5_CRF_c4591001-1178-11781138.pdf
125742_S1_M5_CRF_c4591001-1178-11781164.pdf
125742_S1_M5_CRF_c4591001-1178-11781167.pdf
125742_S1_M5_CRF_c4591001-1178-11781257.pdf
125742_S1_M5_CRF_c4591001-1178-11781287.pdf
125742_S1_M5_CRF_c4591001-1178-11781293.pdf
125742_S1_M5_CRF_c4591001-1178-11781300.pdf
125742_S1_M5_CRF_c4591001-1185-11851055.pdf
125742_S1_M5_CRF_c4591001-1194-11941002.pdf
125742_S1_M5_CRF_c4591001-1194-11941033.pdf
125742_S1_M5_CRF_c4591001-1194-11941058.pdf
125742_S1_M5_CRF_c4591001-1207-12071055.pdf
125742_S1_M5_CRF_c4591001-1213-12131049.pdf
125742_S1_M5_CRF_c4591001-1214-12141018.pdf
125742_S1_M5_CRF_c4591001-1214-12141039.pdf
125742_S1_M5_CRF_c4591001-1217-12171031.pdf
125742_S1_M5_CRF_c4591001-1217-12171039.pdf
125742_S1_M5_CRF_c4591001-1217-12171044.pdf
125742_S1_M5_CRF_c4591001-1218-12181001.pdf
125742_S1_M5_CRF_c4591001-1218-12181012.pdf
125742_S1_M5_CRF_c4591001-1218-12181015.pdf
125742_S1_M5_CRF_c4591001-1218-12181023.pdf
125742_S1_M5_CRF_c4591001-1218-12181046.pdf
125742_S1_M5_CRF_c4591001-1218-12181051.pdf
125742_S1_M5_CRF_c4591001-1218-12181057.pdf
125742_S1_M5_CRF_c4591001-1220-12201020.pdf
125742_S1_M5_CRF_c4591001-1220-12201044.pdf
125742_S1_M5_CRF_c4591001-1220-12201052.pdf
125742_S1_M5_CRF_c4591001-1221-12211002.pdf
125742_S1_M5_CRF_c4591001-1221-12211007.pdf
125742_S1_M5_CRF_c4591001-1223-12231014.pdf
125742_S1_M5_CRF_c4591001-1223-12231024.pdf
125742_S1_M5_CRF_c4591001-1223-12231058.pdf
125742_S1_M5_CRF_c4591001-1223-12231075.pdf
125742_S1_M5_CRF_c4591001-1223-12231159.pdf
125742_S1_M5_CRF_c4591001-1223-12231166.pdf
125742_S1_M5_CRF_c4591001-1223-12231181.pdf
125742_S1_M5_CRF_c4591001-1223-12231182.pdf
125742_S1_M5_CRF_c4591001-1223-12231252.pdf
125742_S1_M5_CRF_c4591001-1224-12241065.pdf
125742_S1_M5_CRF_c4591001-1229-12291083.pdf
125742_S1_M5_CRF_c4591001-1230-12301025.pdf
125742_S1_M5_CRF_c4591001-1230-12301045.pdf
125742_S1_M5_CRF_c4591001-1248-12481120.pdf
125742_S1_M5_CRF_c4591001-1248-12481163.pdf
125742_S1_M5_CRF_c4591001-1248-12481218.pdf
125742_S1_M5_CRF_c4591001-1251-12511029.pdf
125742_S1_M5_CRF_c4591001-1251-12511031.pdf
125742_S1_M5_CRF_c4591001-1251-12511033.pdf
125742_S1_M5_CRF_c4591001-1251-12511050.pdf
125742_S1_M5_CRF_c4591001-1251-12511060.pdf
125742_S1_M5_CRF_c4591001-1251-12511072.pdf
125742_S1_M5_CRF_c4591001-1251-12511145.pdf
125742_S1_M5_CRF_c4591001-1251-12511239.pdf
125742_S1_M5_CRF_c4591001-1251-12511250.pdf
125742_S1_M5_CRF_c4591001-1251-12511262.pdf
125742_S1_M5_CRF_c4591001-1252-12521010.pdf
125742_S1_M5_CRF_c4591001-1252-12521011.pdf
125742_S1_M5_CRF_c4591001-1254-12541006.pdf
125742_S1_M5_CRF_c4591001-1254-12541014.pdf
125742_S1_M5_CRF_c4591001-1254-12541109.pdf
125742_S1_M5_CRF_c4591001-1254-12541142.pdf
125742_S1_M5_CRF_c4591001-1254-12541145.pdf
125742_S1_M5_CRF_c4591001-1254-12541189.pdf
125742_S1_M5_CRF_c4591001-1260-12601018.pdf
125742_S1_M5_CRF_c4591001-1260-12601035.pdf
125742_S1_M5_CRF_c4591001-1260-12601037.pdf
125742_S1_M5_CRF_c4591001-1260-12601069.pdf
125742_S1_M5_CRF_c4591001-1260-12601075.pdf
125742_S1_M5_CRF_c4591001-1260-12601108.pdf
125742_S1_M5_CRF_c4591001-1260-12601128.pdf
125742_S1_M5_CRF_c4591001-1261-12611006.pdf
125742_S1_M5_CRF_c4591001-1264-12641133.pdf
125742_S1_M5_CRF_c4591001-1264-12641195.pdf
125742_S1_M5_CRF_c4591001-1264-12641229.pdf
125742_S1_M5_CRF_c4591001-1265-12651101.pdf
125742_S1_M5_CRF_c4591001-1265-12651149.pdf
125742_S1_M5_CRF_c4591001-1270-12701057.pdf
125742_S1_M5_CRF_c4591001-1270-12701069.pdf
125742_S1_M5_CRF_c4591001-1270-12701142.pdf
Screenshots er fra de første frigivene dokumenter
